Schedule 13D ownership disclosure

ALPINE IMMUNE SCIENCES INC

Security class unavailable · CUSIP: 02083G100

Event date: 2023-11-09

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
7.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000947871-23-001055
Form type
SC 13D/A
Filer
ALPINE IMMUNE SCIENCES, INC.
CIK
CIK 1626199
Filed
Nov 13, 2023
Reporting period
Nov 09, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub